Source: International Congress 2019 – Tuberculosis: diagnosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Izquierdo-Garcia (Donostia, Spain), P. Comella-Del-Barrio (Badalona, Spain), R. Campos-Olivas (Madrid, Spain), F. Casanova (Aachen, Germany), J. Dominguez (Badalona, Spain), J. Ruiz-Cabello (Donostia, Spain). Benchtop NMR-based metabolomic analysis as a diagnostic tool for tuberculosis in clinical urine samples. 3021

Member's Comments

No comment yet.

Related content which might interest you: New approaches to tuberculosis diagnosis through the study of metabolomic profile in urine Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 The identification of tuberculosis biomarkers in human urine samples Source: Eur Respir J 2014; 43: 1719-1729 Year: 2014 Phospholipids qualitative analysis: A new diagnostic tool to characterize ABCA3-Associated disease and guide genetic analysis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Preliminary proteomics analysis for sepsis biomarkers with iTRAQ labeling and LC-MS/MS Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Metabolomic fingerprinting in the identification of biomarkers in COPD patients Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Discrimination of sepsis metabolic profiles revealed by LC/MS-MS based metabonomics approach Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Lung cancer detection by computer assisted analysis of novel biomarkers in induced sputum samples Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Quantitative proteomic analysis: methods and applications Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004 Identification of pleural infection microbiological patterns by applying next generation sequencing and bioinformatics analysis Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Comparative study of three different methods of breath sampling for VOCs detection using IMS analyzer Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Next-generation sequencing and assessment of tumour mutational burden: are these tools ready for clinical routine use? Source: International Congress 2019 – Molecular profiling and personalised treatment concepts in advanced non-small cell lung cancer: pertinent clinical dilemmas Year: 2019 A data management and analysis platform for RASP-UK multiomics clinical datasets Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Evaluation of new biomarkers for laboratory diagnosis of tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test Source: Eur Respir J 2001; 18: Suppl. 33, 360s Year: 2001